Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Breast Cancer (Tokyo, Japan)|April 26, 2017
A phase II, multicenter, single-arm study of tri-weekly low-dose nanoparticle albumin-bound paclitaxel chemotherapy for patients with metastatic or recurrent breast cancerShigeru Yamamoto, Noriko Maeda, Yukiko Nagashima, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 1, 2013
Germline copy number variations associated with breast cancer susceptibility in a Japanese populationYutaka Suehiro, Takae Okada, Naoya Shikamoto, et al.
BMC Cancer|February 2, 2024
High serum proteinase-3 levels predict poor progression-free survival and lower efficacy of bevacizumab in metastatic colorectal cancerKei Furuya, Masao Nakajima, Ryouichi Tsunedomi, et al.
Cancer Science|August 26, 2016
Calreticulin is highly expressed in pancreatic cancer stem-like cellsSatoshi Matsukuma, Kiyoshi Yoshimura, Tomio Ueno, et al.
International Journal of Clinical Oncology|April 12, 2020
Serum LOX-1 is a novel prognostic biomarker of colorectal cancerChiyo Nakashima-Nakasuga, Shoichi Hazama, Nobuaki Suzuki, et al.
Japanese Journal of Clinical Oncology|October 2, 2024
A randomized phase III study evaluating dexamethasone-based mouthwash to prevent chemotherapy-induced stomatitis in patients with breast cancerSayaka Kuba, Sakiko Soutome, Yasuhiro Hagiwara, et al.
Anticancer Research|July 31, 2014
Predictive biomarkers for the outcome of vaccination of five therapeutic epitope peptides for colorectal cancerShoichi Hazama, Hiroko Takenouchi, Ryouichi Tsunedomi, et al.
Oncology Letters|February 3, 2018
Expression levels of UL16 binding protein 1 and natural killer group 2 member D affect overall survival in patients with gastric cancer following gastrectomyRyoji Kamei, Kiyoshi Yoshimura, Shigefumi Yoshino, et al.
Scientific Reports|November 22, 2025
Novel organoid-based exploration reveals the role of LMTK3/FADS2 signaling in metastatic breast cancer progression in felines and humansHaru Yamamoto, Mohamed Elbadawy, Ryouichi Tsunedomi, et al.
Pageof 6